Morbital Plus 400 mg/1 ml roztwór do wstrzykiwań
Morbital Plus 400 mg/1 ml roztwór do wstrzykiwań
Zugelassen
- Pentobarbital sodium
Produktidentifikation
Arzneimittel:
Morbital Plus 400 mg/1 ml roztwór do wstrzykiwań
Wirkstoff:
- Verfügbar nur in englisch
Zieltierarten:
-
Rind
-
Pferd
-
Schwein
-
Hund
-
Katze
Art der Anwendung:
-
intracardiale Anwendung
-
intravenöse Anwendung
-
intraperitoneale Anwendung
Produktdetails
Wirkstoff und Stärke:
-
Verfügbar nur in englisch400.00/milligram(s)1.00millilitre(s)
Darreichungsform:
-
Injektionslösung
Wartezeit(en) per Anwendungsart:
-
intracardiale Anwendung
-
Rind
-
Alle Zielgewebeno withdrawal periodNot applicable. Appropriate measures must be taken to ensure that tissues of animals that have received this product, as well as animal by-products derived from these animals, do not enter the food chain and are not used for consumption by humans or other animals.
-
-
Pferd
-
Alle Zielgewebeno withdrawal periodNot applicable. Appropriate measures must be taken to ensure that tissues of animals that have received this product, as well as animal by-products derived from these animals, do not enter the food chain and are not used for consumption by humans or other animals.
-
-
Schwein
-
Alle Zielgewebeno withdrawal periodNot applicable. Appropriate measures must be taken to ensure that tissues of animals that have received this product, as well as animal by-products derived from these animals, do not enter the food chain and are not used for consumption by humans or other animals.
-
-
-
intravenöse Anwendung
-
Rind
-
Alle Zielgewebeno withdrawal periodNot applicable. Appropriate measures must be taken to ensure that tissues of animals that have received this product, as well as animal by-products derived from these animals, do not enter the food chain and are not used for consumption by humans or other animals.
-
-
Pferd
-
Alle Zielgewebeno withdrawal periodNot applicable. Appropriate measures must be taken to ensure that tissues of animals that have received this product, as well as animal by-products derived from these animals, do not enter the food chain and are not used for consumption by humans or other animals.
-
-
Schwein
-
Alle Zielgewebeno withdrawal periodNot applicable. Appropriate measures must be taken to ensure that tissues of animals that have received this product, as well as animal by-products derived from these animals, do not enter the food chain and are not used for consumption by humans or other animals.
-
-
-
intraperitoneale Anwendung
-
Rind
-
Alle Zielgewebeno withdrawal periodNot applicable. Appropriate measures must be taken to ensure that tissues of animals that have received this product, as well as animal by-products derived from these animals, do not enter the food chain and are not used for consumption by humans or other animals.
-
-
Pferd
-
Alle Zielgewebeno withdrawal periodNot applicable. Appropriate measures must be taken to ensure that tissues of animals that have received this product, as well as animal by-products derived from these animals, do not enter the food chain and are not used for consumption by humans or other animals.
-
-
Schwein
-
Alle Zielgewebeno withdrawal periodNot applicable. Appropriate measures must be taken to ensure that tissues of animals that have received this product, as well as animal by-products derived from these animals, do not enter the food chain and are not used for consumption by humans or other animals.
-
-
Anatomisch-therapeutisch-chemischer Veterinärcode (ATCvet-Code):
- QN51AA01
Abgaberegelung:
Zulassungsstatus:
-
Zulassung gültig
Zugelassen in:
-
Polen
Packungsbeschreibung:
- Verfügbar nur in polieren
Zusätzliche Informationen
Anspruchstyp:
- Verfügbar nur in englisch französisch kroatisch italienisch lettisch finnisch schwedisch isländisch Norwegian
Rechtsgrundlage der Produktzulassung:
Zulassungsinhaber:
- Biowet Pulawy Sp. z o.o.
Zulassungsdatum:
Für die Chargenfreigabe zuständige Produktionsstätten:
- Biowet Pulawy Sp. z o.o.
Zuständige Behörde:
- Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Zulassungsnummer:
- 3218
Tag der Änderung des Zulassungsstatus:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Dokumente
Zusammenfassung der Merkmale des Arzneimittels
Dieses Dokument existiert in dieser Sprache nicht (deutsch). Sie finden es in einer anderen Sprache unten.
polieren (PDF)
Veröffentlicht am: 7/06/2023
Packungsbeilage
Dieses Dokument existiert in dieser Sprache nicht (deutsch). Sie finden es in einer anderen Sprache unten.
polieren (PDF)
Veröffentlicht am: 7/06/2023
Etikettierung
Dieses Dokument existiert in dieser Sprache nicht (deutsch). Sie finden es in einer anderen Sprache unten.
polieren (PDF)
Veröffentlicht am: 7/06/2023